SanBio Company SNBIF Stock
SanBio Company Price Chart
SanBio Company SNBIF Financial and Trading Overview
| SanBio Company stock price | 16.45 USD |
| Previous Close | 16.45 USD |
| Open | 3.85 USD |
| Bid | 5.6 USD x 10000 |
| Ask | 6.6 USD x 10000 |
| Day's Range | 3.85 - 3.85 USD |
| 52 Week Range | 3.85 - 16.45 USD |
| Volume | 1K USD |
| Avg. Volume | 0 USD |
| Market Cap | 1.28B USD |
| Beta (5Y Monthly) | 0.282 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SNBIF Valuation Measures
| Enterprise Value | -12028844032 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 15.108157 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 3.223 |
Trading Information
SanBio Company Stock Price History
| Beta (5Y Monthly) | 0.282 |
| 52-Week Change | 151.14% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 16.45 USD |
| 52 Week Low | 3.85 USD |
| 50-Day Moving Average | 16.45 USD |
| 200-Day Moving Average | 16.45 USD |
SNBIF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 78.04M |
| Float | 56.81M |
| Short Ratio | N/A |
| % Held by Insiders | 24.92% |
| % Held by Institutions | 8.07% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2026 |
| Most Recent Quarter (mrq) | April 30, 2026 |
| Next Fiscal Year End | January 31, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.96% |
| Return on Equity (ttm) | -43.18% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -3731902976 USD |
| Net Income Avi to Common (ttm) | -3146510080 USD |
| Diluted EPS (ttm) | -0.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14B USD |
| Total Cash Per Share (mrq) | 179.33 USD |
| Total Debt (mrq) | 1.18B USD |
| Total Debt/Equity (mrq) | 9.31 USD |
| Current Ratio (mrq) | 52.997 |
| Book Value Per Share (mrq) | 1.0888158 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of SanBio Company
| Country | United States |
| State | N/A |
| City | Tokyo |
| Address | St. Luke Tower |
| ZIP | 104-0044 |
| Phone | 81 3 6264 3481 |
| Website | https://www.sanbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system. It develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. The company's research pipeline products also comprise SB623 for chronic cerebral infarction and chronic traumatic cerebral infarction injury, chronic cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, spinal cord injury, Parkinson's disease, Alzheimer's disease, etc.; SB618 for peripheral neuropathy; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Q&A For SanBio Company Stock
What is a current SNBIF stock price?
SanBio Company SNBIF stock price today per share is 16.45 USD.
How to purchase SanBio Company stock?
You can buy SNBIF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SanBio Company?
The stock symbol or ticker of SanBio Company is SNBIF.
Which industry does the SanBio Company company belong to?
The SanBio Company industry is Biotechnology.
How many shares does SanBio Company have in circulation?
The max supply of SanBio Company shares is 78.04M.
What is SanBio Company Price to Earnings Ratio (PE Ratio)?
SanBio Company PE Ratio is now.
What was SanBio Company earnings per share over the trailing 12 months (TTM)?
SanBio Company EPS is -0.33 USD over the trailing 12 months.
Which sector does the SanBio Company company belong to?
The SanBio Company sector is Healthcare.